While research and the USA largely get by just fine without ISO lab standards and this paper therefore does not mention them, it does illustrate the effects of analogous bureaucracy in the marked decline of clinical research. Food and Drug Administration (FDA) in vitro diagnostic (IVD) product regulations, conflict of interest policies, and institutional review board (IRB) policies regarding consent and confidentiality all work against research.
“Some laboratory directors now find the IRB process at their institutions to be so onerous that they have chosen to reduce or eliminate research activities. Thus, some directors have found the returns from these activities not to be worth the effort expended and feel disincentivized to perform this work.”
These are reducing once-dynamic, research-led professions to dull and dumbed-down trades.
The graph of papers submitted to this American journal illustrates well the striking decline in a heavily-regulated and insolvent nation like the USA and the growth that continues in freer lands.
Lots of inspection recorded. Less good done.